Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas

European Journal of Cancer

Volumn 39, Issue 5, 2003, Pages 684-690

  Humbey, O ^a   Cairey Remonnay, S ^a   Guerrini J S ^a   Algros, M P ^a   Mougin, C ^a   Bittard, H ^a   Aubin, F ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Human papillomavirus; Penile squamous cell carcinoma; TP53 polymorphism

Indexed keywords

ARGININE; VIRUS DNA;

ADULT; ARTICLE; CARCINOGENESIS; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA POLYMORPHISM; EXON; GENE AMPLIFICATION; GENETIC ANALYSIS; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PENIS CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VIRUS DETECTION; VIRUS TYPING; WART VIRUS; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOSITY LOSS; PAPILLOMA VIRUS; PENIS TUMOR; TUMOR SUPPRESSOR GENE; VIROLOGY; VIRUS INFECTION;

ADULT; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; EXONS; GENES, P53; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS; POLYMORPHISM, GENETIC; TUMOR VIRUS INFECTIONS;

EID: 0037333549     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00835-3     Document Type: Article

References (36)

1. Graham S., Priore R., Graham M., Browne R., Burnett W., West D. Genital cancer in wives of penile cancer patients. Cancer. 44:1979;1870-1874.
2. Malek R.S., Goellner J.R., Smith T.F., Espy M.J., Cupp M.R. Human papillomavirus infection and intraepithelial, in situ, and invasive carcinoma of penis. Urology. 42:1993;159-170.
3. Chan K.W., Lam K.Y., Chan A.C., Lau P., Srivastava G. Prevalence of human papillomavirus types 16 and 18 in penile carcinoma. a study of 41 cases using PCR J. Clin. Pathol. 47:1994;823-826.
4. Tornesello M.L., Buonaguro F.M., Beth-Giraldo E., Kyalwazi S.K., Giraldo G. Human papillomavirus (HPV) DNA in penile carcinomas and in two cell lines from high-incidence areas for genital cancers in Africa. Int. J. Cancer. 51:1992;587-592.
5. Picconi M.A., Eijan A.M., Distefano A.L.et al. Human papillomavirus (HPV) DNA in penile carcinomas in Argentina. analysis of primary tumors and lymph nodes J. Med. Virol. 61:2000;65-69.
6. Levi J.E., Rahal P., Sarkis A.S., Villa L. Human papillomavirus DNA and p53 status in penile carcinomas. Int. J. Cancer. 76:1998;779-783.
7. Villa L.L., Lopes A. Human papillomavirus DNA sequences in penile carcinomas in Brazil. Int. J. Cancer. 37:1986;853-8555.
8. Gregoire L., Cubilla A.L., Reuter V.E., Haas G.P., Lancaster W.D. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J. Natl. Cancer Inst. 87:1995;1705-1709.
9. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
10. Storey A., Thomas M., Kalita A.et al. Role of a p53 polymorphism in the development of human papillomavirus- associated cancer. Nature. 393:1998;229-234.
11. O'Connor D.P., Kay E.W., Leader M., Atkins G.J., Murphy G.M., Mabruk M.J. p53 codon 72 polymorphism and human papillomavirus associated skin cancer. J. Clin. Pathol. 54:2001;539-542.
12. Bastiaens M.T., Struyk L., Tjong-A-Hung S.P.et al. Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism. a need for screening? Mol. Carcinog. 30:2001;56-61.
13. Dokianakis D.N., Koumantaki E., Billiri K., Spandidos D.A. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated non-melanoma skin cancers in immunocompetent hosts. Int. J. Mol. Med. 5:2000;405-409.
14. Aubin F., Puzenat E., Arveux P., Louvat P., Quencez E., Humbert P. Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998. Br. J. Dermatol. 144:2001;1204-1206.
15. Saiki R.K., Bugawan T.L., Horn G.T., Mullis K.B., Erlich H.A. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature. 324:1986;163-166.
16. Manos M.M., Ting Y., Wright D.K., Lewis A.J., Broker T.R., Wolinsky S.M. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells. 7:1989;209-214.
17. Riethmuller D., Gay C., Bertrand X.et al. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction. Diagn. Mol. Pathol. 8:1999;157-164.
18. Forslund O., Antonsson A., Nordin P., Stenquist B., Hansson B.G. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J. Gen. Virol. 80:1999;2437-2443.
19. Meyer T., Arndt R., Christophers E., Stockfleth E. Frequency and spectrum of HPV types detected in cutaneous squamous-cell carcinomas depend on the HPV detection system: a comparison of four PCR assays. Dermatology. 201:2000;204-211.
20. Hayes V.M., Hofstra R.M., Buys C.H., Hollema H., van der Zee A.G. Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet. 352:1998;1756.
21. Dillner J., von Krogh G., Horenblas S., Meijer C.J. Etiology of squamous cell carcinoma of the penis. Scand. J. Urol. Nephrol. Suppl. 205:2000;189-193.
22. Sarkar F.H., Miles B.J., Plieth D.H., Crissman J.D. Detection of human papillomavirus in squamous neoplasm of the penis. J. Urol. 47:1992;389-392.
23. Maden C., Sherman K.J., Beckmann A.M.et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J. Natl. Cancer Inst. 85:1993;19-24.
24. Wiener J.S., Effert P.J., Humphrey P.A., Yu L., Liu E.T., Walther P.J. Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis. a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction Int. J. Cancer. 50:1992;694-701.
25. Suzuki H., Sato N., Kodama T.et al. Detection of human papillomavirus DNA and state of p53 gene in Japanese penile cancer. Jpn. J. Clin. Oncol. 24:1994;1-6.
26. Bezerra A.L., Lopes A., Santiago G.H., Ribeiro K.C., Latorre M.R., Villa L.L. Human papillomavirus as a prognostic factor in carcinoma of the penis. analysis of 82 patients treated with amputation and bilateral lymphadenectomy Cancer. 91:2001;2315-2321.
27. Human Papillomaviruses. IARC edition, Vol. 64. 1995;IARC, Lyon.
28. Barraso R., Jablonska S. Clinical, colposcopic and histologic spectrum of male human papillomavirus-associated genital lesions. Clin. Pract. Gynecol. 2:1989;73-102.
29. de Villiers E.M. Human papillomavirus infections in skin cancers. Biomed. Pharmacother. 52:1998;26-33.
30. Matlashewski G.J., Tuck S., Pim D., Lamb P., Schneider J., Crawford L.V. Primary structure polymorphism at amino acid residue 72 of human p53. Mol. Cell Biol. 7:1987;961-963.
31. Marshall S.E., Bordea C., Haldar N.A.et al. Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. Kidney Int. 58:2000;2186-2193.
32. Beckman G., Birgander R., Sjalander A.et al. Is p53 polymorphism maintained by natural selection? Hum. Hered. 44:1994;266-270.
33. Humbey, O., Aubin, F., Cairey-Remonnay, S., et al. TP53 polymorphism at exon 4 in caucasian women from Eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions. Eur J Obstet Gyn Reprod Biol (in press).
34. Cairey-Remonnay S, Humbey O, Mougin C, et al. TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with HPV status. J Invest Dermatol (in press).
35. Quinn A.G., Sikkink S., Rees J.L. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res. 54:1994;4756-4759.
36. McGregor J.M., Harwood C.A., Brooks L.et al. Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J. Invest. Dermatol. 119:2002;84-90.